EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Effect of Daily Vitamin D Supplementation on Risk of Upper Respiratory Infection in Older Adults: A Randomized Controlled Trial

Carlos A Camargo iD, Debra A Schaumberg, Georgina Friedenberg, Rimma Dushkes, Robert J Glynn, Diane R Gold, Samia Mora iD, I Min Lee, Julie E Buring, JoAnn E Manson iD

Clinical Infectious Diseases · 2024

DOI: 10.1093/cid/ciad770 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Carlos A Camargo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Respiratory Tract Infections, Dietary Supplements, Vitamin D. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCCIH NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Among individuals with vitamin D deficiency, daily vitamin D supplementation appears to lower risk of acute respiratory infection. However, recent trials, in different populations and using different regimens, have yielded null results. We investigated the effect of daily vitamin D supplementation (vs placebo) on risk of upper respiratory infection (URI) in older adults.

Methods

The VITamin D and OmegA-3 TriaL (VITAL) is a randomized, double-blind, placebo-controlled trial of supplemental vitamin D and/or omega-3 fatty acids in generally healthy men (age ≥50 years) and women (age ≥55 years). This prespecified analysis focuses on vitamin D3 (2000 IU/day) versus placebo in the 15 804 (61%) participants with baseline serum total 25-hydroxyvitamin D level. The primary outcome was self-report of a recent URI at 1-year follow-up.

Results

Participants had a mean age of 68 years and 51% were women; 76% were non-Hispanic White, 16% Black, and 8% other race/ethnicity. The mean 25-hydroxyvitamin D level at baseline was 31 (standard deviation, 10) ng/mL, with <12 ng/mL in 2.4%. The overall effect of vitamin D supplementation on recent URI was nonsignificant (odds ratio [OR], 0.96 [95% confidence interval {CI}, .86–1.06]). In the prespecified subgroup of primary interest (<12 ng/mL and denied taking concurrent vitamin D), which had only 255 participants, vitamin D supplementation was nonsignificant (OR, 0.60 [95% CI, .28–1.30]). Statistical power to assess effect modification in other subgroups was limited.

Conclusions

In older adults not selected for vitamin D deficiency, supplemental vitamin D did not lower URI risk overall. Whether effects differ in subgroups requires further study. Clinical Trials Registration. NCT01169259.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Tract InfectionsDietary SupplementsVitamin DHumansMaleFemaleAgedDouble-Blind MethodMiddle AgedVitamin D DeficiencyFatty Acids, Omega-3

Stichwörter der Autor:innen

adultsnutritional supplementrandomized controlled trialupper respiratory infectionvitamin D

Substanzen

Vitamin DFatty Acids, Omega-3

Autor:innen und Institutionen

  • Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Carlos A Camargo, Samia Mora, JoAnn E Manson

Förderung

  • NIAID NIH HHS
  • NCCIH NIH HHS
  • NCI NIH HHS
  • NIH
  • NHLBI NIH HHS

Zitieren

APA

Camargo, C. A., Schaumberg, D. A., Friedenberg, G., Dushkes, R., Glynn, R. J., Gold, D. R., Mora, S., Lee, I. M., Buring, J. E., & Manson, J. E. (2024). Effect of Daily Vitamin D Supplementation on Risk of Upper Respiratory Infection in Older Adults: A Randomized Controlled Trial. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad770

Vancouver

Camargo CA, Schaumberg DA, Friedenberg G, Dushkes R, Glynn RJ, Gold DR, et al. Effect of Daily Vitamin D Supplementation on Risk of Upper Respiratory Infection in Older Adults: A Randomized Controlled Trial. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciad770

BibTeX
@article{Camargo2024,
  author = {Camargo, Carlos A and Schaumberg, Debra A and Friedenberg, Georgina and Dushkes, Rimma and Glynn, Robert J and Gold, Diane R and Mora, Samia and Lee, I Min and Buring, Julie E and Manson, JoAnn E},
  title = {Effect of Daily Vitamin D Supplementation on Risk of Upper Respiratory Infection in Older Adults: A Randomized Controlled Trial},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  doi = {10.1093/cid/ciad770}
}
Kostenlos starten →